MacArthur Carol J, Kempton J Beth, DeGagne Jacqueline, Trune Dennis R
Oregon Hearing Research Center, Department of Otolaryngology-Head and Neck Surgery, Oregon Health and Science University, Portland, OR, USA.
Otolaryngol Head Neck Surg. 2008 Nov;139(5):646-53. doi: 10.1016/j.otohns.2008.07.029.
The impact of glucocorticoids and mineralocorticoids on chronic otitis media (COM) in toll-like receptor 4-deficient C3H/HeJ mice was investigated.
To evaluate control of COM by steroids with differences in their anti-inflammatory (prednisolone, dexamethasone), and fluid absorption functions (fludrocortisone, aldosterone). A minimum sample size of five animals for each group was required based on power analysis calculations. Sample sizes ranged from 7 to 17 mice per treatment group.
Auditory brain stem response (ABR) thresholds were performed at baseline, 2 weeks and 4 weeks. Histopathologic test results were evaluated on all mice ears at the end of the study.
Analysis of variance (ANOVA) of ABR threshold change showed significant treatment effects (P < 0.05) by both steroid types at all time intervals and ABR frequencies except 4 weeks/8 kHz. Histologic assessment showed prednisolone-treated mice (62%) had a higher rate of clearance of middle and inner ear inflammation than control mice (4%).
It was concluded that steroid treatments can improve the physiology of chronic middle and inner ear disease seen with COM.
研究糖皮质激素和盐皮质激素对 toll 样受体 4 缺陷的 C3H/HeJ 小鼠慢性中耳炎(COM)的影响。
评估具有不同抗炎作用(泼尼松龙、地塞米松)和液体吸收功能(氟氢可的松、醛固酮)的类固醇对 COM 的控制情况。根据功效分析计算,每组至少需要五只动物作为样本。每个治疗组的样本量为 7 至 17 只小鼠。
在基线、2 周和 4 周时进行听性脑干反应(ABR)阈值检测。在研究结束时对所有小鼠的耳朵进行组织病理学检测。
ABR 阈值变化的方差分析(ANOVA)显示,除 4 周/8kHz 外,在所有时间间隔和 ABR 频率下,两种类固醇类型均有显著的治疗效果(P < 0.05)。组织学评估显示,泼尼松龙治疗的小鼠(62%)中耳和内耳炎症清除率高于对照小鼠(4%)。
得出的结论是,类固醇治疗可改善 COM 所见的慢性中耳和内耳疾病的生理状况。